{"id":171898,"date":"2020-06-09T17:14:54","date_gmt":"2020-06-09T21:14:54","guid":{"rendered":"https:\/\/www.countingpips.com\/?p=171898"},"modified":"2020-06-09T16:15:33","modified_gmt":"2020-06-09T20:15:33","slug":"aurora-cannabis-upside-breakout-looks-imminent","status":"publish","type":"post","link":"https:\/\/www.investmacro.com\/forex\/2020\/06\/aurora-cannabis-upside-breakout-looks-imminent\/","title":{"rendered":"Aurora Cannabis ‘Upside Breakout Looks Imminent’"},"content":{"rendered":"
June 9, 2020<\/div>
\r\n<\/div><\/div>

By The Life Science Report – <\/b>Source: Clive Maund for Streetwise Reports<\/em> \u00a0\u00a006\/08\/2020<\/a><\/b><\/p>\n

Technical analyst Clive Maund charts the cannabis company and explains why he calls it an “immediate strong buy.”<\/strong><\/p>\n

Further to its being recommended a few days back<\/a> for an upside breakout from the current bull Pennant pattern leading to another sharp upleg, this brief update is to point out that the pattern in Aurora Cannabis Inc. (ACB:NYSE; ACB:TSX)<\/a> looks even more bullish now with a continued steady volume dieback, so that at the time of writing only about 3 million shares have been traded so far today compared with over 100 million in one day when it blasted higher in the middle of May. The volume pattern looks very bullish indeed and is consistent with a bull Pennant completing, and volume is now so light relatively speaking that an upside breakout looks imminent.<\/i><\/p>\n

 <\/p>\n

<\/a><\/center>Aurora Cannabis is therefore rated AN IMMEDIATE STRONG BUY for another sharp upleg that is expected to commence very soon.<\/p>\n

Another upleg in this large cannabis stock should have a positive effect on many stocks across the sector, including Icanic Brands that we went for a day later than Aurora<\/a>.<\/p>\n

Aurora Cannabis website<\/a>.<\/p>\n

Aurora Cannabis Inc., ACB, ACB.TSX, trading at $14.27, C$19.20 on 4th June 2020.<\/p>

\r\n
\r\n

Free Reports:<\/p><\/div>\r\n

\r\n

<\/a>\r\n\t Get Our Free Metatrader 4 Indicators<\/u><\/b><\/a> - Put Our Free MetaTrader 4 Custom Indicators on your charts when you join our Weekly Newsletter<\/p>

\r\n
\r\n
\r\n

<\/a>\r\n\t Get our Weekly Commitment of Traders Reports<\/u><\/b><\/a> - See where the biggest traders (Hedge Funds and Commercial Hedgers) are positioned in the futures markets on a weekly basis.<\/p>

\r\n<\/div>\r\n

\r\n
<\/div>\n

Originally posted on CliveMaund.com at 2.05 pm EDT on 4th June 2020.
\n<\/i><\/p>\n

Clive Maund<\/i><\/a> has been president of www.clivemaund.com, a successful resource sector website, since its inception in 2003. He has 30 years’ experience in technical analysis and has worked for banks, commodity brokers and stockbrokers in the City of London. He holds a Diploma in Technical Analysis from the UK Society of Technical Analysts.<\/p>\n

Sign up for our FREE newsletter at: www.streetwisereports.com\/get-news<\/a><\/p>\n

Disclosure: <\/b>
\n1) Clive Maund: I, or members of my immediate household or family, own shares of the following companies mentioned in this article: None. I personally am, or members of my immediate household or family are, paid by the following companies mentioned in this article: None. My company has a financial relationship with the following companies mentioned in this article: None. CliveMaund.com disclosures below. I determined which companies would be included in this article based on my research and understanding of the sector.
\n2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here<\/a> for important disclosures about sponsor fees.
\n3) Statements and opinions expressed are the opinions of the author and not of Streetwise Reports or its officers. The author is wholly responsible for the validity of the statements. The author was not paid by Streetwise Reports for this article. Streetwise Reports was not paid by the author to publish or syndicate this article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
\n4) This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer<\/a>. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
\n5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and\/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases.<\/p>\n

Charts provided by the author.<\/p>\n

CliveMaund.com Disclosure:
\nThe above represents the opinion and analysis of Mr Maund, based on data available to him, at the time of writing. Mr. Maund’s opinions are his own, and are not a recommendation or an offer to buy or sell securities. Mr. Maund is an independent analyst who receives no compensation of any kind from any groups, individuals or corporations mentioned in his reports. As trading and investing in any financial markets may involve serious risk of loss, Mr. Maund recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction and do your own due diligence and research when making any kind of a transaction with financial ramifications. Although a qualified and experienced stock market analyst, Clive Maund is not a Registered Securities Advisor. Therefore Mr. Maund’s opinions on the market and stocks can only be construed as a solicitation to buy and sell securities when they are subject to the prior approval and endorsement of a Registered Securities Advisor operating in accordance with the appropriate regulations in your area of jurisdiction.<\/i><\/p>\n

<\/p>\n

( Companies Mentioned: ACB:NYSE; ACB:TSX,
\n)<\/p>\n

<\/a> <\/a><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

By The Life Science Report – Source: Clive Maund for Streetwise Reports \u00a0\u00a006\/08\/2020 Technical analyst Clive Maund charts the cannabis company and explains why he calls it an “immediate strong buy.” Further to its being recommended a few days back for an upside breakout from the current bull Pennant pattern leading to another sharp upleg, […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-171898","post","type-post","status-publish","format-standard","hentry","no-post-thumbnail"],"_links":{"self":[{"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/posts\/171898","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/comments?post=171898"}],"version-history":[{"count":2,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/posts\/171898\/revisions"}],"predecessor-version":[{"id":171900,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/posts\/171898\/revisions\/171900"}],"wp:attachment":[{"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/media?parent=171898"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/categories?post=171898"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/tags?post=171898"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}